Physician

Amber M Patterson, M.D.

According to 2025 Medicare claims, Amber Patterson, M.D. (NPI: 1104082957) practices allergy/immunology, with the plurality of this provider's patient population coming from Hancock, OH. This provider's primary affiliated billing organization is ALLERGY UNLIMITED, LLC (NPI: 1801505235; TIN: 843819395) and primary practice location at 45840-9998.

Patterson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 107 traditional Medicare patients, billed 4,071 HCPCS/CPT codes, and received $40,650 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 314 prescription claims across 94 beneficiaries totaling $204,209 in drug costs, led by Nucala (Mepolizumab). DME data shows 153 claims. Open Payments data shows 69 records totaling $32,359. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $3,552 to $3,564.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	67	2,845	$21,934
2016	168	7,359	$60,734
2017	205	10,945	$96,783
2018	242	12,126	$97,889
2019	237	9,101	$69,164
2020	224	7,884	$64,526
2021	231	8,020	$65,259
2022	206	7,293	$53,442
2023	88	3,671	$33,877
2024	107	4,071	$40,650

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	41	94	$17,247
2016	114	418	$229,421
2017	144	713	$623,973
2018	140	806	$1,001,204
2019	142	686	$832,273
2020	143	664	$667,500
2021	145	707	$671,577
2022	130	558	$563,437
2023	93	345	$471,562
2024	94	314	$204,209

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	115	$103,268
2018	N/R	224	$282,223
2019	N/R	288	$414,801
2020	N/R	322	$480,429
2021	41	418	$654,885
2022	23	367	$586,303
2023	11	264	$425,936
2024	N/R	153	$247,177

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	23	23	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	67	115	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	32	40	$65
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	27	27	$55
95004	Test for allergy using allergenic extract	36	2,649	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nucala	Mepolizumab	21	588	$84,212
Xolair	Omalizumab	19	560	$44,561
Breo Ellipta	Fluticasone/Vilanterol	12	420	$5,798
Epinephrine	Epinephrine	13	338	$3,315
Ipratropium Bromide	Ipratropium Bromide	33	1,557	$1,270

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	48	$194,463
J1558	Injection, immune globulin (xembify), 100 mg	N	N/R	11	$49,255
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	31	$2,596
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	63	$862

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	68	$20,624	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$11,735	SANOFI US SERVICES INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amber M. Patterson, M.D.?

Tedicare shows public-source Medicare data for Amber M. Patterson, M.D. (NPI 1104082957), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amber M. Patterson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amber M. Patterson, M.D.?

Amber M. Patterson, M.D. is linked to ALLERGY UNLIMITED, LLC (billing NPI 1801505235) in the available physician profile data.

Does Amber M. Patterson, M.D. have Open Payments data?

Amber M. Patterson, M.D. has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.